Project Grant K24HL186030

This Project Grant, awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), provides $131,880 in federal funding to support mentored patient-oriented translational research on community-acquired pneumonia and the host immune response to critical illness. The award, issued July 10, 2026, with a completion date of April 30, 2031, is administered through the University of Washington's Office of Sponsored Programs and focuses on research mentorship and training. The principal investigator, a mid-career pulmonary and critical care physician and Associate Professor of Medicine at the University of Washington, will lead research examining heterogeneity in host responses during critical illness syndromes, with the objective of developing more personalized prevention and treatment strategies for severe pneumonia and pneumonia-related organ failure.

The core products and services delivered under this award include mentoring and career development support for pre- and post-doctoral trainees across multiple disciplines including pulmonary and critical care medicine, nephrology, infectious diseases, and general internal medicine. The award supports the principal investigator's established mentoring program, which has previously yielded over 15 first-author publications, five NIH or foundation grants, and two career development awards among trainees, with 63% of program graduates remaining in academic research careers. Through protected research time and institutional resources, the award enables continued development of the principal investigator's translational research group and the pipeline of future physician-scientists in critical illness and infectious disease research.